Fluorescence in situ hybridization (FISH) is a powerful technique used in the detection of
chromosomal abnormalities. The high sensitivity and specificity of FISH and the speed with …

Lung cancer is a devastating disease and a major therapeutic burden with poor survival
rates. It is responsible for 30% of all cancer deaths. Lung cancer is strongly associated with …

The management of hematologic malignancies, including chronic myeloid leukemia (CML),
chronic lymphocytic leukemia (CLL), and acute lymphocytic leukemia (ALL), has led the way …

Simple Summary In recent years, immunotherapy has emerged as a pillar in the fight against
cancer. However, the heterogeneity within the tumor microenvironment poses challenges to …

For the first time, we have successfully synthesized stable graphene nanosheets from
graphite powder through sonication in the hemoglobin-capped gold nanoclusters (Hb …

Simple Summary Chronic Myelogenous Leukemia (CML) is a common blood cancer that
involves the uncontrolled growth of certain blood cells. Treating this disease effectively …

This atlas presents not only the differential diagnosis but also the detailed morphologic,
immunophenotypic, and especially genetic characteristics of the majority of hematolymphoid …

Abstract Background: For Philadelphia chromosome positive (Ph+) leukemias (chronic
myelogenous leukemia [CML], acute lymphoblastic leukemia [ALL], and rare other …

Fluorescent in situ hybridization has become an essential tool for diagnosing and monitoring
hematological disease. Testing for minimal residual disease requires precise and accurate …

Emerging genomic and proteomic data is creating new opportunities to identify novel
biomarkers that will have pathway-specific therapeutic impact on cancer progression …